20.7 C
Auckland
Thursday, December 12, 2024

Popular Now

Study highlights elevated risks of cerebral thromboembolism after COVID-19 jab

Cerebral thromboembolism study news

A recent population-based retrospective cohort study has revealed significantly higher rates of adverse events (AEs) involving cerebral thromboembolism (CTE) following COVID-19 ‘vaccination’ compared to influenza vaccines and all other vaccines administered since 1990.

The findings, based on data from the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS), raise critical questions about vaccine safety.

Cerebral thromboembolism is a medical condition where a blood clot blocks blood flow to a part of the brain. This can happen when a clot forms in another part of the body, like the heart, and travels through the bloodstream until it gets stuck in a blood vessel in the brain.

The study analysed 5137 CTE-related AEs reported within the three years following the rollout of COVID-19 vaccines. In stark contrast, only 52 CTE-related AEs were reported over 34 years for influenza vaccines, and 282 for all other vaccines combined over the same period.

Using proportional reporting ratio (PRR) analysis adjusted for time, the study found that the risk of CTE-related AEs after COVID-19 vaccination was over 1000 times greater compared to influenza vaccines and over 200 times higher compared to all other vaccines combined. These results were statistically significant, with p-values well below 0.0001.

Cerebral venous thromboembolism (CVT) emerged as the predominant subtype of CTE, disproportionately affecting women. Women were 1.63 times more likely than men to experience CVT (95% confidence interval: 1.52–1.74). Meanwhile, cerebral arterial thromboembolism (CAT) showed a nonsignificant male preponderance.

The most common identified cause of CVT, atrial fibrillation, was also significantly more frequent after COVID-19 vaccination compared to all other vaccines, with a PRR of 123 (95% confidence interval: 88.3–172, p < 0.0001).

The researchers concluded that the observed rates of CTE-related AEs after COVID-19 vaccines exceed established safety thresholds. They recommended an immediate global moratorium on the use of COVID-19 vaccines, emphasising an urgent need for contraindications, particularly for women of reproductive age.

Image credit: Robina Weermeijer

Promoted Content

No login required to comment. Name, email and web site fields are optional. Please keep comments respectful, civil and constructive. Moderation times can vary from a few minutes to a few hours. Comments may also be scanned periodically by Artificial Intelligence to eliminate trolls and spam.

3 COMMENTS

  1. It had been studied in animals for years, this was known.
    In a 2017 paper Moderna reported their product was not safe for humans.

  2. Where is Medsafe and CARM’s studies and research?
    Where is the reporting ? Where are the warnings?
    Is anyone in New Zealand suitably Medically trained and equipped to advise on this issue or have we all been left under a cloud of dishonesty and under reporting the entire time?
    Shameful.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest

Trending

Sport

Daily Life

Opinion

Wellington
light rain
18.8 ° C
18.8 °
18.8 °
72 %
8.2kmh
20 %
Thu
18 °
Fri
19 °
Sat
19 °
Sun
19 °
Mon
17 °